This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03921/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03921/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB03921/identifier/chemspider/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03921/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03921/identifier/bindingdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03921/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03921
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB03921 n15:DB03921
dcterms:title
4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
adms:identifier
n6:394909 n7:DB03921 n8:21492 n9:46505424 n10:PY1 n11:447966
n3:IUPAC-Name
n4:271B4FF0-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4FF6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4FF5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4FF2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4FF3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4FF4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4FEE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4FEC-363D-11E5-9242-09173F13E4C5 n4:271B4FEF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4FED-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4FFC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4FFD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4FF7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4FF8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4FFA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4FF9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4FFB-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5002-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5004-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5005-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5001-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5000-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5003-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4FF1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4FFE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4FFF-363D-11E5-9242-09173F13E4C5